Personalized treatments require complex supply chain and manufacturing processes
-- Non-traditional scenarios like autologous, allogeneic, clinic or enhanced traditional processes are driving the complexity.
Designing cell & gene therapy management systems
Orchestrating end-to-end processes from order placement through to patient delivery.
Today, there are no standard processes and solutions available when it comes to cell therapies. Getting the architecture right is key. We are investing in SAP S/4HANA as a core to our integrated solution for personalized medicine, as we see great potential in SAP S/4HANA and the built-in functionalities in SAP R/3 or SAP ECC.
/tenthpin_lifeSciencesinnovation_final_no%20bg.svg)
Pioneering an SAP-based solution for commercial operations
Tenthpin partnered with a Top 5 pharma company to rapidly design, develop, and deploy an SAP-based cell & gene therapy treatment management solution. Covering the end-to-end process from order placement through patient delivery, the solution was deployed for the commercial operations of one of the world’s first approved cell & gene therapies.
Designing and deploying a cloud-based industry standard
Tenthpin partnered with a major software and pharma company to design and deliver a cloud-based solution for cell & gene treatment management. The solution will become an industry standard and enable leading capabilities for biopharma companies, including:
Traceability and transparency (COI & COC)
External supplier (CMO) engagement
Supply chain visualization
Shipping and logistics management
.svg)
/tenthpin_about_us_final_no_bg.svg)
Why is Tenthpin in the lead?
As one of the leading consulting firms for Life Sciences, Tenthpin understands the effort required for an end-to-end supply chain. We have partnered with key leaders in the industry to design, develop, and deploy an SAP-based cell & gene therapy treatment management solutions.
Are you prepared for the era of personalized treatments?
Connect with our experts to learn more about Cell & Gene Treatment Orchestration.
Dan Silva
Partner, USA
Michael Schmidt
Partner & Member of the Executive Board, Switzerland
INSIGHTS
Related insights
Many Life Sciences companies recognize the need to innovate, but struggle with where and how to begin. That’s not a surprise....
AI is no longer a future ambition in Life Sciences, it is here. Executives are under pressure to move beyond pilots and deliver...
Innovation is critical, but it’s also complex. In the highly regulated, data-intensive world of Life Sciences, success requires...
